| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Human papillomavirus in oral exfoliated cells and risk of head and neck cancer.
|
J Natl Cancer Inst
|
2004
|
3.43
|
|
2
|
Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.
|
Cancer Res
|
2007
|
2.93
|
|
3
|
Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx.
|
Int J Cancer
|
2003
|
2.69
|
|
4
|
Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers.
|
Int J Cancer
|
2004
|
2.59
|
|
5
|
Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents.
|
Pediatr Infect Dis J
|
2007
|
1.88
|
|
6
|
Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission.
|
Sex Transm Dis
|
2004
|
1.80
|
|
7
|
Competency assessment of residents in surgical pathology using virtual microscopy.
|
Hum Pathol
|
2009
|
1.54
|
|
8
|
Human papillomavirus seropositivity and risks of head and neck cancer.
|
Int J Cancer
|
2007
|
1.39
|
|
9
|
P16INK4a expression, human papillomavirus, and survival in head and neck cancer.
|
Oral Oncol
|
2007
|
1.30
|
|
10
|
Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers.
|
Cancer Causes Control
|
2010
|
1.30
|
|
11
|
Thymocytes, pre-B cells, and organ changes in a mouse model of chronic ethanol ingestion--absence of subset-specific glucocorticoid-induced immune cell loss.
|
Alcohol Clin Exp Res
|
2007
|
1.29
|
|
12
|
Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease.
|
J Oncol
|
2012
|
1.27
|
|
13
|
Alcohol dehydrogenase 3 and risk of squamous cell carcinomas of the head and neck.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.13
|
|
14
|
Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer.
|
Int J Cancer
|
2010
|
1.12
|
|
15
|
Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers.
|
J Virol
|
2010
|
1.08
|
|
16
|
Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study.
|
Infect Agent Cancer
|
2011
|
1.01
|
|
17
|
Evidence for vertical transmission of HPV from mothers to infants.
|
Infect Dis Obstet Gynecol
|
2010
|
1.00
|
|
18
|
The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes.
|
J Virol
|
2008
|
0.99
|
|
19
|
Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.96
|
|
20
|
Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer.
|
Infect Agent Cancer
|
2010
|
0.93
|
|
21
|
Human papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVs.
|
J Virol
|
2009
|
0.90
|
|
22
|
Head and neck cancer associated with herpes simplex virus 1 and 2 and other risk factors.
|
Oral Oncol
|
2006
|
0.89
|
|
23
|
Prevalence and persistence of human papillomavirus in postmenopausal age women.
|
Cancer Detect Prev
|
2003
|
0.88
|
|
24
|
Association between p53 and human papillomavirus in head and neck cancer survival.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.88
|
|
25
|
Functional mapping of the human papillomavirus type 16 E1 cistron.
|
J Virol
|
2008
|
0.86
|
|
26
|
Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in culture.
|
J Virol
|
2009
|
0.85
|
|
27
|
Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes.
|
Virology
|
2010
|
0.83
|
|
28
|
Cellular factor YY1 downregulates the human papillomavirus 16 E6/E7 promoter, P97, in vivo and in vitro from a negative element overlapping the transcription-initiation site.
|
J Gen Virol
|
2009
|
0.81
|
|
29
|
Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1.
|
Carcinogenesis
|
2009
|
0.81
|
|
30
|
The truncated C-terminal E2 (E2-TR) protein of bovine papillomavirus (BPV) type-1 is a transactivator that modulates transcription in vivo and in vitro in a manner distinct from the E2-TA and E8^E2 gene products.
|
Virology
|
2012
|
0.79
|
|
31
|
Analyzing the Human Papillomavirus (HPV) Life Cycle in Primary Keratinocytes with a Quantitative Colony-Forming Assay.
|
Curr Protoc Microbiol
|
2014
|
0.79
|
|
32
|
A Web-based database for pathology faculty effort reporting.
|
Hum Pathol
|
2008
|
0.75
|